What is bulbar palsy?

What is Bulbar Palsy?

Bulbar palsy is a lower motor neuron syndrome caused by progressive degeneration of the motor nuclei in the medulla (cranial nerves IX, X, XI, and XII), resulting in weakness and atrophy of the muscles controlling swallowing, speech, and secretion management. 1, 2

Core Clinical Features

Bulbar palsy manifests through a constellation of symptoms arising from weakness of the bulbar muscles:

• Dysphagia (swallowing difficulties) is the hallmark feature, characterized by difficulty managing food in the mouth, impaired bolus formation, delayed swallowing initiation, and markedly increased aspiration risk 1, 2
• Dysarthria results from weakness of the tongue, palate, and pharyngeal muscles, producing slurred, indistinct speech 2, 3
• Sialorrhea (drooling) occurs because patients cannot efficiently clear saliva and have poor lip seal 1, 2
• Tongue atrophy and fasciculations are characteristic lower motor neuron signs visible on examination 3, 4
• Nasal regurgitation reflects reduced soft-palate closure during swallowing 1, 2
• Excessive accumulation of secretions that patients cannot manage effectively 3, 4

Pathophysiology

The underlying mechanism involves:

• Progressive degeneration of motor nuclei in the medulla oblongata affecting cranial nerves IX (glossopharyngeal), X (vagus), XI (accessory), and XII (hypoglossal) 2, 3
• Lower motor neuron signs including muscle weakness, atrophy, fasciculations, and absent reflexes—distinguishing it from pseudobulbar palsy which shows upper motor neuron signs 2
• Oral phase impairments including poor lip seal leading to drooling, impaired tongue mobility affecting bolus formation and propulsion, and food trapping in the buccal sulcus 1
• Pharyngeal phase impairments including reduced soft-palate closure causing nasal regurgitation, delayed bolus transport from oral cavity to pharynx, and decreased pharyngeal contraction 1

Disease Progression Pattern

Bulbar palsy follows a predictable but variable progression:

• Early signs include prolonged meal times, fatigue during eating, and difficulty chewing certain food textures 1, 2
• Progressive stages advance through normal eating habits → early eating problems → dietary consistency modifications needed → tube feeding requirement → nothing by mouth 1
• Advanced manifestations include severe dysphagia requiring alternative feeding methods and complete inability to manage oral secretions 1, 2

Life-Threatening Complications

Bulbar dysfunction leads to serious complications that drive morbidity and mortality:

• Aspiration pneumonia occurs in 11.4-13% of cases and represents a major cause of death 1, 2, 5
• Malnutrition and weight loss develop in 0-21% of patients at diagnosis, adversely affecting survival and quality of life 1, 2
• Respiratory complications arise from inability to clear airway debris due to inadequate peak cough flows, upper airway obstruction from laryngeal and pharyngeal muscle weakness, and abnormal respiratory patterns during swallowing 5
• Chronic malnutrition from bulbar muscle weakness has considerable bearing on respiratory muscle function and survival 5

Distinction from Pseudobulbar Palsy

Critical differences separate true bulbar palsy from pseudobulbar palsy:

• Pseudobulbar palsy is an upper motor neuron syndrome with hyperreflexia, emotional lability (pathological laughing/crying), and a brisk jaw-jerk reflex 2
• True bulbar palsy shows lower motor neuron signs with absent or diminished reflexes, muscle atrophy, and fasciculations 2

Common Etiologies

Bulbar palsy occurs in several disease contexts:

• Motor neuron disease (ALS) is the most common cause, with bulbar-onset ALS representing a distinct presentation pattern 1, 6
• Progressive bulbar palsy can occur as an isolated syndrome or as part of motor neuron disease spectrum 3, 7, 4
• Brown-Vialetto-Van Laere syndrome and Fazio-Londe syndrome represent childhood forms caused by mutations in riboflavin transporter genes (SLC52A2 and SLC52A3), which are treatable with early riboflavin supplementation 7
• Immune checkpoint inhibitor-induced myositis causes bulbar symptoms in approximately 1% of patients receiving cancer immunotherapy, with median onset at 4 weeks of treatment 8
• Guillain-Barré syndrome variants can present with bulbar weakness combined with cranial symptoms 2, 8

Critical Clinical Pitfalls

Several dangerous errors must be avoided:

• Allowing oral intake before formal swallowing assessment dramatically increases aspiration risk 2
• Failing to test for treatable causes such as myasthenia gravis (anti-acetylcholine receptor antibodies) or riboflavin-transporter mutations can miss curable conditions 2, 7
• Underestimating respiratory compromise because bulbar dysfunction can mask typical signs of respiratory distress 2
• Delayed gastrostomy placement after significant respiratory decline markedly raises procedural risk; PEG should be placed before vital capacity falls below 50% predicted 2